Dhodapkar, Madhav V.
Fred Hutchinson Cancer Center,
United States
2025 Rank: 24825
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 491 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24825 | 20280 |
| Total Cites | 1280 | 1466 |
| H-index | 19 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 30 | 40 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 129 | 153 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 392 | 483 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1092 | 1165 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
12.69%
|
|
Dhodapkar, Madhav V.
Emory University,
United States
2024 Rank: 24634
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 508 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24634 | 21176 |
| Total Cites | 1239 | 1421 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 23 | 28 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 162 | 187 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 449 | 537 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1056 | 1129 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
12.81%
|
|
Dhodapkar, Madhav V.
Emory University,
United States
2023 Rank: 20919
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 493 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20919 | 23423 |
| Total Cites | 1399 | 1504 |
| H-index | 21 | 21 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 183 | 188 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 482 | 509 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1177 | 1239 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
6.98%
|
|
Dhodapkar, Madhav V.
Emory University,
United States
2022 Rank: 21439
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 577 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21439 | 20719 |
| Total Cites | 1455 | 1602 |
| H-index | 20 | 21 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 16 | 19 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 170 | 184 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 476 | 526 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1241 | 1318 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
9.18%
|
|
Dhodapkar, Madhav V.
Emory University,
United States
2021 Rank: 19286
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 488 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19286 | 16439 |
| Total Cites | 2064 | 2323 |
| H-index | 24 | 26 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 30 | 39 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 286 | 324 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 732 | 845 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1750 | 1885 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.23 |
| Self-Citation Percentage |
11.15%
|
|
Dhodapkar, Madhav V.
Emory University,
United States
2020 Rank: 24792
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 575 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24792 | 22987 |
| Total Cites | 1306 | 1446 |
| H-index | 18 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 18 | 24 |
| Number of Single+First Authored Papers | 63 | 63 |
| Total Cites to Single+First Authored Papers | 223 | 250 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 504 | 564 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1116 | 1186 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
9.68%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.